Works by Mahlangu, Johnny

Results: 69
    1
    2
    3
    4

    Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5959, doi. 10.3390/jcm10245959
    By:
    • Kenet, Gili;
    • Chen, Yeu-Chin;
    • Lowe, Gillian;
    • Percy, Charles;
    • Tran, Huyen;
    • von Drygalski, Annette;
    • Trossaërt, Marc;
    • Reding, Mark;
    • Oldenburg, Johannes;
    • Mingot-Castellano, Maria Eva;
    • Park, Young-Shil;
    • Peyvandi, Flora;
    • Ozelo, Margareth C.;
    • Mahlangu, Johnny;
    • Quinn, Jennifer;
    • Huang, Mei;
    • Reddy, Divya B.;
    • Kim, Benjamin
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.

    Published in:
    Haemophilia, 2025, v. 31, n. 1, p. 78, doi. 10.1111/hae.15109
    By:
    • Dunn, Amy;
    • Dargaud, Yesim;
    • Abajas, Yasmina;
    • Carcao, Manuel;
    • Castaman, Giancarlo;
    • Giermasz, Adam;
    • Hermans, Cédric;
    • Jiménez‐Yuste, Victor;
    • Lewandowska, Magdalena;
    • Mahlangu, Johnny;
    • Meeks, Shannon;
    • Miesbach, Wolfgang;
    • Recht, Michael;
    • Salinas, Vanessa;
    • Chrisentery‐Singleton, Tammuella;
    • Bonzo, Daniel;
    • Mitchell, Ian S.;
    • Wilkinson, Thomas A.;
    • Young, Guy
    Publication type:
    Article
    17
    18
    19
    20

    Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.

    Published in:
    Haemophilia, 2022, v. 28, n. 4, p. 548, doi. 10.1111/hae.14563
    By:
    • Pipe, Steven W.;
    • Hermans, Cédric;
    • Chitlur, Meera;
    • Carcao, Manuel;
    • Castaman, Giancarlo;
    • Davis, Joanna A.;
    • Ducore, Jonathan;
    • Dunn, Amy L.;
    • Escobar, Miguel;
    • Journeycake, Janna;
    • Khan, Osman;
    • Mahlangu, Johnny;
    • Meeks, Shannon L.;
    • Mitha, Ismail Haroon;
    • Négrier, Claude;
    • Nowak‐Göttl, Ulrike;
    • Recht, Michael;
    • Chrisentery‐Singleton, Tammuella;
    • Stasyshyn, Oleksandra;
    • Vilchevska, Kateryna V.
    Publication type:
    Article
    21
    22
    23
    24
    25

    Cover Image.

    Published in:
    Haemophilia, 2021, v. 27, n. 6, p. i, doi. 10.1111/hae.14463
    By:
    • Escobar, Miguel;
    • Castaman, Giancarlo;
    • Boix, Santiago Bonanad;
    • Callaghan, Michael;
    • de Moerloose, Philippe;
    • Ducore, Jonathan;
    • Hermans, Cédric;
    • Journeycake, Janna;
    • Leissinger, Cindy;
    • Luck, James;
    • Mahlangu, Johnny;
    • Miesbach, Wolfgang;
    • Mitha, Ismail Haroon;
    • Négrier, Claude;
    • Quon, Doris;
    • Recht, Michael;
    • Schved, Jean François;
    • Shapiro, Amy D.;
    • Sidonio, Robert;
    • Srivastava, Alok
    Publication type:
    Article
    26
    27

    The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.

    Published in:
    Haemophilia, 2021, v. 27, n. 6, p. 921, doi. 10.1111/hae.14419
    By:
    • Escobar, Miguel;
    • Castaman, Giancarlo;
    • Boix, Santiago Bonanad;
    • Callaghan, Michael;
    • de Moerloose, Philippe;
    • Ducore, Jonathan;
    • Hermans, Cédric;
    • Journeycake, Janna;
    • Leissinger, Cindy;
    • Luck, James;
    • Mahlangu, Johnny;
    • Miesbach, Wolfgang;
    • Mitha, Ismail Haroon;
    • Négrier, Claude;
    • Quon, Doris;
    • Recht, Michael;
    • Schved, Jean François;
    • Shapiro, Amy D.;
    • Sidonio, Robert;
    • Srivastava, Alok
    Publication type:
    Article
    28

    PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.

    Published in:
    Haemophilia, 2021, v. 27, n. 6, p. 911, doi. 10.1111/hae.14418
    By:
    • Escobar, Miguel;
    • Luck, James;
    • Averianov, Yevhenii;
    • Ducore, Jonathan;
    • Fernández, Maria Fernanda López;
    • Giermasz, Adam;
    • Hart, Daniel P.;
    • Journeycake, Janna;
    • Kessler, Craig;
    • Leissinger, Cindy;
    • Mahlangu, Johnny;
    • Martinez, Laura Villarreal;
    • Miesbach, Wolfgang;
    • Mitha, Ismail Haroon;
    • Quon, Doris;
    • Reding, Mark T.;
    • Schved, Jean‐François;
    • Stasyshyn, Oleksandra;
    • Vilchevska, Kateryna V.;
    • Wang, Michael
    Publication type:
    Article
    29

    The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies.

    Published in:
    Haemophilia, 2021, v. 27, n. 5, p. 854, doi. 10.1111/hae.14363
    By:
    • Skinner, Mark W.;
    • Négrier, Claude;
    • Paz‐Priel, Ido;
    • Chebon, Sammy;
    • Jiménez‐Yuste, Victor;
    • Callaghan, Michael U.;
    • Lehle, Michaela;
    • Niggli, Markus;
    • Mahlangu, Johnny;
    • Shapiro, Amy;
    • Shima, Midori;
    • Campinha‐Bacote, Avrita;
    • Levy, Gallia G.;
    • Oldenburg, Johannes;
    • von Mackensen, Sylvia;
    • Pipe, Steven W.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35

    Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study.

    Published in:
    Haemophilia, 2020, v. 26, n. 6, p. e262, doi. 10.1111/hae.14036
    By:
    • Pasi, K. John;
    • Fischer, Kathelijn;
    • Ragni, Margaret;
    • Kulkarni, Roshni;
    • Ozelo, Margareth C.;
    • Mahlangu, Johnny;
    • Shapiro, Amy;
    • P'Ng, Stephanie;
    • Chambost, Hervé;
    • Nolan, Beatrice;
    • Bennett, Carolyn;
    • Matsushita, Tadashi;
    • Winding, Bent;
    • Fruebis, Joachim;
    • Yuan, Huixing;
    • Rudin, Dan;
    • Oldenburg, Johannes
    Publication type:
    Article
    36

    WFH Guidelines for the Management of Hemophilia, 3rd edition.

    Published in:
    Haemophilia, 2020, v. 26, n. 6, p. 1, doi. 10.1111/hae.14046
    By:
    • Srivastava, Alok;
    • Santagostino, Elena;
    • Dougall, Alison;
    • Kitchen, Steve;
    • Sutherland, Megan;
    • Pipe, Steven W.;
    • Carcao, Manuel;
    • Mahlangu, Johnny;
    • Ragni, Margaret V.;
    • Windyga, Jerzy;
    • Llinás, Adolfo;
    • Goddard, Nicholas J.;
    • Mohan, Richa;
    • Poonnoose, Pradeep M.;
    • Feldman, Brian M.;
    • Lewis, Sandra Zelman;
    • Berg, H. Marijke;
    • Pierce, Glenn F.
    Publication type:
    Article
    37

    World Federation of Hemophilia Gene Therapy Registry.

    Published in:
    Haemophilia, 2020, v. 26, n. 4, p. 563, doi. 10.1111/hae.14015
    By:
    • Konkle, Barbara A.;
    • Coffin, Donna;
    • Pierce, Glenn F.;
    • Clark, Cary;
    • George, Lindsey;
    • Iorio, Alfonso;
    • Mahlangu, Johnny;
    • Naccache, Mayss;
    • O'Mahony, Brian;
    • Peyvandi, Flora;
    • Pipe, Steve;
    • Quartel, Adrian;
    • Sawyer, Eileen K.;
    • Skinner, Mark W.;
    • Tortella, Bartholomew;
    • Watson, Crystal;
    • Winburn, Ian
    Publication type:
    Article
    38

    Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table.

    Published in:
    Haemophilia, 2020, v. 26, n. 3, p. 443, doi. 10.1111/hae.13971
    By:
    • Pierce, Glenn F.;
    • Pasi, K. John;
    • Coffin, Donna;
    • Kaczmarek, Radoslaw;
    • Lillicrap, David;
    • Mahlangu, Johnny;
    • Rottellini, Dawn;
    • Sannié, Thomas;
    • Srivastava, Alok;
    • VandenDriessche, Thierry;
    • Weill, Alain;
    • Almeida, Antonio J.;
    • Baumann, Alain;
    • Brooker, Mark;
    • Durante, Luisa;
    • Naccache, Mayss;
    • Robinson, Fiona
    Publication type:
    Article
    39
    40
    41

    Health‐related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non‐interventional study (NIS).

    Published in:
    Haemophilia, 2019, v. 25, n. 3, p. 382, doi. 10.1111/hae.13731
    By:
    • Mahlangu, Johnny;
    • Lehle, Michaela;
    • Macharia, Harrison;
    • Asikanius, Elina;
    • Kruse‐Jarres, Rebecca;
    • von Mackensen, Sylvia;
    • Oldenburg, Johannes;
    • Callaghan, Michael U.;
    • Shima, Midori;
    • Mancuso, Maria Elisa;
    • Trask, Peter;
    • Levy, Gallia G.;
    • Recht, Michael;
    • Garcia, Claudia;
    • Yang, Renchi
    Publication type:
    Article
    42
    43
    44
    45
    46

    Efficacy and safety of a VWF/ FVIII concentrate (wilate<sup>®</sup>) in inherited von Willebrand disease patients undergoing surgical procedures.

    Published in:
    Haemophilia, 2017, v. 23, n. 2, p. 264, doi. 10.1111/hae.13106
    By:
    • Srivastava, A.;
    • Serban, M.;
    • Werner, S.;
    • Schwartz, B. A.;
    • Kessler, C. M.;
    • Alkindi, Salam;
    • Apte, Shashikant Janardan;
    • Castaman, Giancarlo;
    • Gill, Joan Cox;
    • Hellmann, Andrzej;
    • Kavakli, Kaan;
    • Kouides, Peter A.;
    • Kuriakose, Philip;
    • Lissitchkov, Toshko;
    • Ma, Alice;
    • Mahlangu, Johnny;
    • Morfini, Massimo;
    • Neufeld, Ellis J.;
    • Peyvandi, Flora;
    • Reding, Mark
    Publication type:
    Article
    47
    48
    49
    50